Table 3.
Multivariable-adjusted associations of risk factors with incident, sporadic colorectal adenoma in three pooled case-control studies (CPRU Study, 1991–1994; MAP I Study, 1994–1997; and MAP II, 2002), stratified by regular non-aspirin NSAID use
| Regular use of non-aspirin NSAID (n = 574) |
No regular use of non-aspirin NSAID (n = 2,250) |
|||||||
|---|---|---|---|---|---|---|---|---|
| Risk factorsa | No. of Cases |
No. of Controls |
OR* | 95% CI | No. of Cases |
No. of Controls |
ORb | 95% CI |
|
Age quartiles (years) | ||||||||
| 1 (≤ 47) | 14 | 132 | 1.00 | Referent | 87 | 420 | 1.00 | Referent |
| 2 (48 – 55) | 31 | 114 | 2.97 | 1.44, 6.10 | 156 | 377 | 2.00 | 1.47, 2.73 |
| 3 (56 – 63) | 41 | 109 | 4.05 | 1.98, 8.26 | 205 | 399 | 2.52 | 1.86, 3.41 |
| 4 (≥ 64) | 29 | 104 | 3.16 | 1.51, 6.61 | 226 | 380 | 3.51 | 2.58, 4.77 |
| Ptrendc | <0.01 | <0.01 | ||||||
| Sex | ||||||||
| Female | 52 | 314 | 1.00 | Referent | 255 | 850 | 1.00 | Referent |
| Male | 63 | 145 | 1.19 | 0.41, 3.47 | 419 | 726 | 0.94 | 0.56, 1.55 |
|
First-degree relative with CRC (%) | ||||||||
| No | 96 | 370 | 1.00 | Referent | 560 | 1,301 | 1.00 | Referent |
| Yes | 19 | 89 | 0.87 | 0.49, 1.54 | 114 | 275 | 1.09 | 0.84, 1.40 |
| Smoking status | ||||||||
| Never | 41 | 183 | 1.00 | Referent | 204 | 755 | 1.00 | Referent |
| Former | 54 | 213 | 0.86 | 0.53, 1.41 | 300 | 600 | 1.47 | 1.18, 1.80 |
| Current | 20 | 63 | 1.75 | 0.90, 3.41 | 170 | 221 | 2.91 | 2.22, 3.82 |
| Ptrendc | 0.27 | <0.01 | ||||||
|
Alcohol consumption | ||||||||
| Non-drinker | 49 | 200 | 1.00 | Referent | 279 | 690 | 1.00 | Referent |
| Low | 24 | 144 | 0.66 | 0.38, 1.17 | 166 | 453 | 0.87 | 0.69, 1.11 |
| High | 42 | 115 | 1.41 | 0.85, 2.36 | 229 | 433 | 1.20 | 0.95, 1.52 |
| Ptrendc | 0.08 | 0.01 | ||||||
|
Body mass index, (kg/m2) | ||||||||
| Normal weight (18.5 – 24.9) |
37 | 163 | 1.00 | Referent | 207 | 636 | 1.00 | Referent |
| Underweight (<18.5) |
0 | 2 | n/a | n/a n/a | 11 | 20 | 1.49 | 0.66, 3.33 |
| Overweight (25.0 – 29.9) |
32 | 148 | 0.73 | 0.41, 1.28 | 292 | 627 | 1.25 | 1.00, 1.56 |
| Obese (≥ 30) | 46 | 146 | 1.19 | 0.69, 2.04 | 164 | 293 | 1.67 | 1.28, 2.17 |
| Ptrendc | 0.44 | 0.06 | ||||||
|
Height, quartiles (inches) | ||||||||
| 1 (≤ 63.5) | 25 | 102 | 1.00 | Referent | 131 | 330 | 1.00 | Referent |
| 2 (63.6 – 65.4) | 29 | 141 | 0.76 | 0.40, 1.43 | 216 | 506 | 1.08 | 0.82, 1.41 |
| 3 (65.5 – 69.4) | 24 | 92 | 0.99 | 0.50, 1.93 | 147 | 314 | 1.20 | 0.89, 1.62 |
| 4 (≥ 69.5) | 37 | 124 | 1.51 | 0.82, 2.80 | 180 | 426 | 1.39 | 1.05, 1.85 |
| Ptrendc | 0.10 | 0.01 | ||||||
|
Physical activity, quartiles | ||||||||
| 1 | 35 | 121 | 1.00 | Referent | 192 | 396 | 1.00 | Referent |
| 2 | 26 | 107 | 0.91 | 0.50, 1.68 | 162 | 394 | 0.89 | 0.69, 1.17 |
| 3 | 25 | 110 | 0.88 | 0.48, 1.62 | 156 | 399 | 0.89 | 0.68, 1.16 |
| 4 | 29 | 121 | 0.94 | 0.52, 1.71 | 164 | 387 | 0.85 | 0.65, 1.11 |
| Ptrendc | 0.86 | 0.31 | ||||||
|
Dietary Intakes Percent calories from total fat, quartiles | ||||||||
| 1 | 30 | 110 | 1.00 | Referent | 152 | 402 | 1.00 | Referent |
| 2 | 21 | 100 | 0.81 | 0.39, 1.67 | 165 | 406 | 1.14 | 0.85, 1.54 |
| 3 | 28 | 119 | 0.92 | 0.38, 2.21 | 176 | 391 | 1.42 | 0.97, 2.06 |
| 4 | 36 | 130 | 1.14 | 0.37, 3.49 | 181 | 377 | 1.57 | 0.96, 2.55 |
| Ptrendc | 0.72 | 0.02 | ||||||
|
Percent calories from saturated fat, quartiles | ||||||||
| 1 | 28 | 99 | 1.00 | Referent | 156 | 414 | 1.00 | Referent |
| 2 | 27 | 118 | 0.76 | 0.38, 1.53 | 183 | 388 | 1.24 | 0.92, 1.67 |
| 3 | 29 | 113 | 0.80 | 0.33, 1.97 | 156 | 396 | 1.15 | 0.79, 1.67 |
| 4 | 31 | 129 | 0.70 | 0.23, 2.15 | 179 | 378 | 1.37 | 0.86, 2.18 |
| Ptrendc | 0.66 | 0.17 | ||||||
|
Dietary fiber, quartiles | ||||||||
| 1 | 25 | 113 | 1.00 | Referent | 164 | 399 | 1.00 | Referent |
| 2 | 25 | 110 | 1.15 | 0.59, 2.27 | 193 | 398 | 1.26 | 0.95, 1.66 |
| 3 | 37 | 114 | 1.52 | 0.74, 3.09 | 158 | 394 | 1.17 | 0.86, 1.59 |
| 4 | 28 | 122 | 1.34 | 0.57, 3.17 | 159 | 385 | 1.26 | 0.87, 1.82 |
| Ptrendc | 0.50 | 0.34 | ||||||
|
Totaldcalcium, quartiles | ||||||||
| 1 | 23 | 118 | 1.00 | Referent | 189 | 394 | 1.00 | Referent |
| 2 | 29 | 112 | 1.36 | 0.70, 2.63 | 179 | 394 | 0.95 | 0.72, 1.25 |
| 3 | 35 | 106 | 2.07 | 1.03, 4.17 | 141 | 404 | 0.72 | 0.53, 0.97 |
| 4 | 28 | 123 | 1.30 | 0.61, 2.75 | 165 | 384 | 0.93 | 0.68, 1.28 |
| Ptrendc | 0.72 | 0.42 | ||||||
|
Totald
folic acid, quartiles | ||||||||
| 1 | 25 | 117 | 1.00 | Referent | 186 | 395 | 1.00 | Referent |
| 2 | 36 | 103 | 1.54 | 0.79, 3.01 | 196 | 404 | 1.04 | 0.78, 1.38 |
| 3 | 33 | 118 | 1.16 | 0.56, 2.40 | 138 | 391 | 0.74 | 0.54, 1.03 |
| 4 | 21 | 121 | 0.73 | 0.34, 1.56 | 154 | 386 | 0.92 | 0.66, 1.28 |
| Ptrendc | 0.10 | 0.49 | ||||||
|
Total fruits & vegetables, quartiles | ||||||||
| 1 | 23 | 113 | 1.00 | Referent | 183 | 391 | 1.00 | Referent |
| 2 | 32 | 112 | 1.62 | 0.86, 3.08 | 180 | 399 | 0.95 | 0.73, 1.23 |
| 3 | 32 | 124 | 1.39 | 0.71, 2.71 | 153 | 394 | 0.83 | 0.62, 1.11 |
| 4 | 28 | 110 | 1.38 | 0.65, 2.94 | 158 | 392 | 0.89 | 0.64, 1.23 |
| Ptrendc | 0.58 | 0.44 | ||||||
|
Total red & processed meats, quartiles | ||||||||
| 1 | 27 | 98 | 1.00 | Referent | 131 | 363 | 1.00 | Referent |
| 2 | 29 | 131 | 0.82 | 0.43, 1.56 | 187 | 462 | 1.07 | 0.80, 1.42 |
| 3 | 29 | 108 | 0.89 | 0.44, 1.81 | 165 | 355 | 1.08 | 0.79, 1.49 |
| 4 | 30 | 122 | 0.70 | 0.31, 1.56 | 191 | 396 | 1.04 | 0.73, 1.49 |
| Ptrendc | 0.42 | 0.86 | ||||||
|
HRT use (women) | ||||||||
| No | 94 | 909 | 1.00 | Referent | 586 | 1,270 | 1.00 | Referent |
| Yes | 21 | 136 | 0.77 | 0.41, 1.42 | 88 | 306 | 0.87 | 0.64, 1.18 |
|
Oxidative balance score, quartilese | ||||||||
| 1 | 37 | 116 | 1.00 | Referent | 260 | 393 | 1.00 | Referent |
| 2 | 34 | 113 | 1.02 | 0.58, 1.79 | 151 | 396 | 0.59 | 0.45, 0.76 |
| 3 | 21 | 121 | 0.67 | 0.35, 1.28 | 143 | 388 | 0.58 | 0.44, 0.77 |
| 4 | 23 | 109 | 0.77 | 0.39, 1.54 | 120 | 399 | 0.50 | 0.37, 0.69 |
| Ptrendc | 0.33 | <0.01 | ||||||
Abbreviations: CPRU, Cancer Prevention Research Unit; CRC, colorectal cancer; CI, confidence interval; HRT, hormone replacement therapy; MAP, Markers of Adenomatous Polyps; MET, metabolic equivalents of task; NSAID, nonsteroidal anti-inflammatory drugs excluding aspirin; OR, odds ratio.
Quartiles of age were based on the distribution among the controls. Quartiles of physical activity were based on the study-specific distribution among the controls. Cutpoints for alcohol intake were based on the sex-specific distribution among the controls and were defined as follows for low / high intake: ≤ 2.5 / > 7 drinks/week among males, and ≤ 1 / > 4 drinks/week among females. Cut-points for height quartiles were based on the sex-specific distribution among the controls and were defined as follows: 67.4, 69.4, and 71.4 inches among men, and 62.5, 63.5, and 65.4 inches among women. Quartiles for all dietary intake variables were based on the sex- and study-specific distribution among controls. Quartiles for the oxidative balance score were based on the study-specific distribution among controls.
Odds ratios and 95% confidence intervals from unconditional logistic regression models. Covariates for all models, except as noted below included age, sex, family history of colorectal cancer in a first-degree relative, smoking, alcohol intake, body mass index, height, physical activity, hormone therapy (among women), regular aspirin use, and total calcium, folate, dietary fiber, total energy, total fat, saturated fat, total fruit and vegetable, and total red and processed meats intakes. The model for fat does not include total saturated fat, the model for saturated fat does not include total fat, the model for dietary fiber does not include total fruits and vegetables, and model for total fruits and vegetables intakes does not include dietary fiber. Covariates for the model for the oxidative balance score include age, sex, education, family history of colorectal cancer in a first-degree relative, regular aspirin use, hormone replacement therapy (among women), and total calcium, total vitamin D, total energy, total folate, and dietary fiber intakes.
Ptrend values (2-sided) were calculated by including the median of each quartile of each variable as a continuous variable in the multivariable models, except the model for body mass index, where the median of the underweight category was excluded.
Total = dietary + supplemental.
Oxidative balance score calculated as described in the Statistical Analysis section of the text; a higher OBS reflects higher antioxidant relative to pro-oxidant dietary and lifestyle exposures.